The PGE2 EP3 receptor regulates diet-induced adiposity in male Mice

Endocrinology

Volumn 157, Issue 1, 2016, Pages 220-232

  Ceddia, Ryan P ^a   Lee, Daekee ^a,b   Maulis, Matthew F ^a   Carboneau, Bethany A ^a   Threadgill, David W ^a,c   Poffenberger, Greg ^a   Milne, Ginger ^a   Boyd, Kelli L ^a   Powers, Alvin C ^a   McGuinness, Owen P ^a   Gannon, Maureen ^a   Breyer, Richard M ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b Ewha Womans University   (South Korea)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 6; ISOPRENALINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E2; TRACE ELEMENT; TUMOR NECROSIS FACTOR ALPHA; PTGER3 PROTEIN, MOUSE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL INFILTRATION; CELL ISOLATION; CELL SIZE; CONTROLLED STUDY; DIET INDUCED OBESITY; DISEASE SEVERITY; EPIDIDYMIS FAT; FAT MASS; FATTY LIVER; GENOTYPE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; LIPOLYSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE NECROSIS; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CROSS BREEDING; DIABETES MELLITUS, TYPE 2; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LIPID METABOLISM; LIVER; MACROPHAGE ACTIVATION; METABOLISM; NECROSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PANNICULITIS; PATHOLOGY; PATHOPHYSIOLOGY; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ADIPOSITY; ANIMALS; CELL SIZE; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MACROPHAGE ACTIVATION; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; NECROSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PANNICULITIS; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; WEIGHT GAIN;

EID: 84954526085     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1693     Document Type: Article

References (51)

1. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008;118(9):2992-3002.
2. Sjöholm A, Nyström T. Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev. 2006;22(1):4-10.
3. Sears DD, Hsiao G, Hsiao A, et al. Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc Natl Acad Sci USA. 2009;106(44):18745-18750.
4. 2 production and inhibition of insulin secretion in pancreatic islets. J Biol Chem. 2012;287(38):32246-32253.
5. 2 mediates inhibition of insulin secretion by interleukin-1β. J Biol Chem. 1999;274(44):31245-31248.
6. 2-induced inflammation: relevance of prostaglandin E receptors. Biochim Biophys Acta. 2015;1851(4):414-421.
7. 2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann Neurol. 2008;64(3):304-314.
8. Murata T, Ushikubi F, Matsuoka T, et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 1997;388(6643):678-682.
9. Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev. 2007;59(3):207-224.
10. Hata AN, Breyer RM. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther. 2004;103(2):147-166.
11. Regard JB, Sato IT, Coughlin SR. Anatomical profiling of G protein coupled receptor expression. Cell. 2008;135(3):561-571.
12. Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol. 2010;6(2):71-82.
13. Masoodi M, Kuda O, Rossmeisl M, Flachs P, Kopecky J. Lipid signaling in adipose tissue: connecting inflammation&metabolism. Biochim Biophys Acta. 2015;1851(4):503-518.
14. Richelsen B. Release and effects of prostaglandins in adipose tissue. Prostaglandins Leukot Essent Fatty Acids. 1992;47(3):171-182.
15. 2-EP4 signaling reduces chemokine production in adipose tissue. J Lipid Res. 2015;56(2):358-368.
16. Iyer A, Lim J, Poudyal H, et al. An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against dietinduced metabolic syndrome in rats. Diabetes. 2012;61(9):2320-2329.
17. Jaworski K, Ahmadian M, Duncan RE, et al. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med. 2009;15(2):159-168.
18. Chaves VE, Frasson D, Kawashita NH. Several agents and pathways regulate lipolysis in adipocytes. Biochimie. 2011;93(10):1631-1640.
19. Granneman JG, Moore HP. Location, location: protein trafficking and lipolysis in adipocytes. Trends Endocrinol Metab. 2008;19(1):3-9.
20. Holm C, Osterlund T, Laurell H, Contreras JA. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr. 2000;20:365-393.
21. Lampidonis AD, Rogdakis E, Voutsinas GE, Stravopodis DJ. The resurgence of hormone-sensitive lipase (HSL) in mammalian lipolysis. Gene. 2011;477(1-2):1-11.
22. Sanchez-Alavez M, Klein I, Brownell SE, et al. Night eating and obesity in the EP3R-deficient mouse. Proc Natl Acad SciUSA. 2007;104(8):3009-3014.
23. Ushikubi F, Segi E, Sugimoto Y, et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature. 1998;395(6699):281-284.
24. Baecker V. ImageJ macro tool sets for biological image analysis. Presented at the Image J User and Developer Conference 2012, Luxembourg, 2012.
25. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497-509.
26. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res. 1964;5:600-608.
27. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.
28. Viswanadha S, Londos C. Optimized conditions for measuring lipolysis in murine primary adipocytes. J Lipid Res. 2006;47(8):1859-1864.
29. Dai C, Brissova M, Hang Y, et al. Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets. Diabetologia. 2012;55(3):707-718.
30. 2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med. 2003;197(2):221-232.
31. Oba K, Hosono K, Amano H, et al. Downregulation of the proangiogenic prostaglandin E receptor EP3 and reduced angiogenesis in a mouse model of diabetes mellitus. Biomed Pharmacother. 2014;68(8):1125-1133.
32. Taniguchi T, Fujino H, Israel DD, Regan JW, Murayama T. Human EP3 (I) prostanoid receptor induces VEGF and VEGF receptor-1 mRNA expression. Biochem Biophys Res Commun. 2008;377(4):1173-1178.
33. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46(11):2347-2355.
34. Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184-6223.
35. Anderson NJ, King MR, Delbruck L, Jolivalt CG. Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in mice. Dis Model Mech. 2014;7(6):625-633.
36. Barnea M, Shamay A, Stark AH, Madar Z. A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity (Silver Spring). 2006;14(12):2145-2153.
37. Sumiyoshi M, Sakanaka M, Kimura Y. Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J Nutr. 2006;136(3):582-587.
38. Ahmadian M, Wang Y, Sul HS. Lipolysis in adipocytes. Int J Biochem Cell Biol. 2010;42(5):555-559.
39. 1 on the mobilization of free fatty acids and glycerol from human adipose tissue in vitro prostaglandin and related factors. Acta Physiol Scand. 1965;63(1-2):195-196.
40. Dalton C, Hope H, Martikes L. Prostaglandin inhibition of cyclic-AMP accumulation and rate of lipolysis in fat cells. Prostaglandins. 1974;7(4):319-326.
41. 1 on lipolysis induced by noradrenaline, isopropylnoradrenaline, theophylline, and dibutyryl cAMP in human omental adipose tissue in vitro. Acta Med Scand. 1970;187(6):503-507.
42. Moskowitz J, Fain JN. Hormonal regulation of lipolysis and phosphorylase activity in human fat cells. J Clin Invest. 1969;48(10):1802-1808.
43. 1 antagonism to norepinephrine and theophylline-induced lipolysis. Eur J Pharmacol. 1967;1(4):321-325.
44. Steinberg D, Vaughan M, Nestel PJ, Strand O, Bergström S. Effects of the prostaglandins on hormone-induced mobilization of free fatty acids. J Clin Invest. 1964;43:1533-1540.
45. 6-phenylisopropyladenosine. Naunyn Schmiedebergs Arch Pharmacol. 1974;282(1):15-31.
46. Alkhouri N, Gornicka A, Berk MP, et al. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem. 2010;285(5):3428-3438.
47. Strissel KJ, Stancheva Z, Miyoshi H, et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes. 2007;56(12):2910-2918.
48. Wueest S, Rapold RA, Schumann DM, et al. Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. J Clin Invest. 2010;120(1):191-202.
49. Tran PO, Gleason CE, Robertson RP. Inhibition of interleukin-1β-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet β-cell function. Diabetes. 2002;51(6):1772-1778.
50. 2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion. Diabetes. 2013;62(6):1904-1912.
51. Shridas P, Zahoor L, Forrest KJ, Layne JD, Webb NR. Group X secretory phospholipase A2 regulates insulin secretion through a cyclooxygenase-2-dependent mechanism. J Biol Chem. 2014;289(40):27410-27417.